AI-assisted, human-published

03/09/2026 /M & A

Servier to Acquire Day One Biopharmaceuticals for $2.5 Billion

French pharmaceutical group Servier is set to acquire Day One Biopharmaceuticals, Inc. for $2.5 billion, reinforcing its presence in oncology targeted therapies.

 

AI-assisted, human-published

Latest headlines







join us

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here

©2023 VentureCapital.com